Products
- Anti-Obesity Compound Library
- GPCR/G Protein-Targeted Compounds
- Immunology/Inflammation-Targeted Compounds
- JAK/STAT-Targeted Compounds
- MAPK-Targeted Compounds
- Membrane Transporter/Ion Channel-Targeted Compounds
- Metabolism-Targeted Compounds
- NF-κB-Targeted Compounds
- Microbiology/Virology-Targeted Compounds
- Neuronal Signaling-Targeted Compounds
- PI3K/Akt/mTOR-Targeted Compounds
- Oxidation-reduction-Targeted Compounds
- Proteases/Proteasome-Targeted Compounds
- Stem Cells/Wnt-Targeted Compounds
- Tyrosine Kinase/Adaptors-Targeted Compounds
- Ubiquitin-Targeted Compounds
Online Inquiry
Metformin
Cat. No.:
0225LY-0509
Appearance:
Solid
Purity:
≥99%
Identity:
Confirmed by NMR, and LC-MS.
Size:
Add to basket
Product Overview
Description:
Metformin is a brain-permeable AMPK activator frequently used in type 2 diabetes studies to enhance insulin sensitivity and lower glucose absorption in the intestines.
Synonym:
1,1-Dimethylbiguanide; 657-24-9; N,N-Dimethylimidodicarbonimidic diamide; Fluamine; Metiguanide; Dimethylbiguanide; N-Dimethylbiguanide
CAS No.:
657-24-9
Compound CID:
4091
Formula:
C4H11N5
Formula Weight:
129.16
Specification
Relative Density:
1.0743 g/cm3
Stability:
3 years in powder form.
Storage:
Storage at -20°C.
Applications:
Metformin can be used in metabolic research or play a vital role in investigating the activation of AMPK and its anti-aging properties.
Library Information
Target:
AMPK
Receptor:
AMPK
Pathways:
Autophagy; Chromatin/Epigenetic; PI3K/Akt/mTOR signaling
Plate Number:
AOCL-7
Plate Location:
e11
Empty Location:
a1-h1; a12-h12
Container:
96-well plate
Formulation:
10mM DMSO
DMSO Max Solubility:
49 mg/mL; 379.37 mM
Water Max Solubility:
100 mg/mL; 774.23 mM
